<DOC>
	<DOCNO>NCT00683345</DOCNO>
	<brief_summary>Fatigue prevalent phenomenon Primary Sjøgrens syndrome ( PSS ) . Observations indicate cytokine IL-1 importance phenomenon . In study investigator block IL-1 give Anakinra ( IL-1 receptor antagonist ) patient PSS .</brief_summary>
	<brief_title>Fatigue Interleukin-1 ( IL-1 ) Blockade Primary Sjøgrens Syndrome</brief_title>
	<detailed_description>A double-blind , placebo-controlled , parallel study effect fatigue daily injection Anakinra one month .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Sjogren 's Syndrome</mesh_term>
	<mesh_term>Interleukin 1 Receptor Antagonist Protein</mesh_term>
	<criteria>Primary Sjøgrens Syndrome accord EuropeanAmerican criterion Age 1880 year Written inform consent Hyper og hypothyreosis Malignant disease Parkinsons disease Multiple sclerosis Conditions diseases Anakinra contraindicate Mental depression ( BDI &gt; 13 ) Neutropenia ( &lt; 1.5*10.9 ) Frequent infection Pregnancy , lactate woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>